Navigation Links
Oral Allergy Immunotherapy Helps Control Asthma
Date:3/4/2008

Drops or tablets avoid the pain and side effects of shots, review finds

TUESDAY, March 4 (HealthDay News) -- Oral allergy immunotherapy -- in the form of drops or tablets -- is effective at reducing asthma symptoms and the need for asthma medications in children who have what's known as allergic asthma, a new study finds.

The findings bolster hopes that these oral medications might someday replace injections, never a hit with kids.

"[Oral] immunotherapy is effective and safe, easy to administer, well-accepted by patients," said the study's senior author, Dr. Giorgio Walter Canonica, professor of allergy and respiratory disease at the Medical University of Genoa, Italy.

Commonly known as allergy shots in the United States, allergy immunotherapy works in a manner similar to vaccines -- essentially re-educating the body's immune system so that it doesn't overreact to harmless substances such as pollen or dust mites. While this therapy can be effective, it's currently only available via injections in the United States, and usually involves at least one to two shots a week for three to six months, making it a less-than-popular alternative with children.

Oral immunotherapy is available in Europe, but has yet to gain Food and Drug Administration approval in the United States.

The new study reviewed nine studies that looked at the use of so-called sublingual (oral) immunotherapy in children with asthma. A total of 441 kids between the ages of 3 and 18 who had been diagnosed with allergic asthma were included in the studies. Allergic asthma means that asthma symptoms can be triggered by exposure to an allergen, such as dust mites, pollen or mold.

Two hundred and thirty-two children received oral immunotherapy and the remaining 209 got a placebo.

The dosing schedule varied depending on the study and whether drops or tablets were used. Canonica said that during the maintenance ph
'/>"/>

Copyright©2008 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Allergy Disorders Linked With Irritable Bowel Syndrome
2. NHS Choices Launches New Food Allergy Symptom Checker
3. Allergy Shots Are Effective Treatment for Symptoms
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Childrens Zyrtec(R) Chewable Tablets for Allergy Relief and Childrens Zyrtec(R) Chewable Tablets for Hives Relief
5. A Few Shots Away: Immunotherapy May Relieve Allergy Symptoms
6. Protein a possible key to allergy and asthma control
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic OTC Versions of Zyrtec Allergy Tablets(R) and Zyrtec Hives Relief Tablets(R)
8. Parents Smoking Boosts Childs Allergy Risk
9. Menopausal Women May Have an Increased Asthma Risk, From The Journal of Allergy and Clinical Immunology
10. Allergy Foundation Thinks Globally, Gifts Locally
11. Tis the Season For Allergy, Asthma
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Oral Allergy Immunotherapy Helps Control Asthma
(Date:8/22/2014)... Vegas, NV (PRWEB) August 22, 2014 ... that uses university-proven research to show people how they can ... lean muscle in only a matter of weeks has caught ... , “Ben Pakulski is one of the most well-known bodybuilders ... get the body he has today, that in itself is ...
(Date:8/22/2014)... a complex autoimmune disease that affects 1 to ... only cope with pain, disability and joint disfigurements, ... family life and marital functioning. While many pharmacological ... disability is common. In addition, some patients avoid ... side effects. Because of this, there is interest ...
(Date:8/22/2014)... 2014 Testosterone treatment lawsuits ( ... courts on behalf of men who allegedly suffered ... prescription low testosterone therapies, Bernstein Liebhard LLP reports. ... filed against Pfizer Inc. on July 31st by ... issues due to his use of Depo-Testosterone. (Case ...
(Date:8/22/2014)... UK (PRWEB) August 22, 2014 The ... recent past, specifically in the developing world, has led ... and the number of deaths due to AIDS globally. ... declining, the number of new patients becoming affected by ... conscious efforts being undertaken by all related organisations and ...
(Date:8/22/2014)... Ohio (PRWEB) August 22, 2014 Dayton Children's ... care tower as part of a $141 million campus renewal. ... patient care tower were unveiled to the public. , ... facilities plan that will create a campus that meets the ... future. These new care spaces will embody Dayton Children’s unique ...
Breaking Medicine News(10 mins):Health News:Mi40x: Review Exposes Ben Pakulski’s Guide to Packing on Lean Muscle Fast 2Health News:Study shows cognitive-behavioral coping skills training has positive effects on rheumatoid arthritis 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 2Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 3Health News:Testosterone Treatment Lawsuit News: New Filing Alleges Depo-Testosterone Caused Life-Threatening Heart Problems, Bernstein Liebhard LLP reports. 4Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 2Health News:Worldwide HIV Infection Drug Market Examined in New Kuick Research Report Published at MarketPublishers.com 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 2Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 3Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 4Health News:Dayton Children's Hospital Breaks Ground on New, Eight-story Patient Care Tower 5
... cells, stem cells derived from human placenta left over ... when they interacted with one kind of melatonin receptor, ... cells were transplanted into laboratory test tube and animal ... perform similarly when interacting with melatonin receptor MT2. ...
... 1, 2011) Positron emission tomography (PET) can ... kinase inhibitor vandetanib, helping to define the therapy ... according to research published in the February issue ... Currently being tested in clinical trials, vandetanib inhibits ...
... Society for Therapeutic Radiology and Oncology (ESTRO), the European ... for Medical Oncology (ESMO) in collaboration with other European ... on the 3rd International Conference on innovative approaches In ... on multidisciplinarity and innovation, this meeting will specifically cover ...
... and ultrasound can mean more targeted breast biopsies for ... and possibly saving those patients from undergoing a second ... Patients with early breast cancer undergo a sentinel lymph ... said Dr. Ali Sever, lead author of the study. ...
... -- Among injection drug users, new cases of HIV infection ... number of new infections from the hepatitis C virus have ... The findings suggest that efforts -- such as needle exchange ... of infectious diseases have been successful against HIV but more ...
... professionals have talked about youth pitching injuries and the stress ... new, 10-year study published in the February issue of the ... participants who pitched more than 100 innings in a year ... study proved a direct link between innings pitched in youth ...
Cached Medicine News:Health News:Transplanted human placenta-derived stem cells show therapeutic potential in stroke models 2Health News:PET scans may allow early prediction of response to targeted therapy of thyroid cancer 2Health News:3rd international conference on innovative approaches in head and neck oncology 2Health News:Microbubble ultrasound and breast biopsies 2Health News:Infectious Disease Experts Call for More Focus on Hepatitis C 2Health News:New 10-year study confirms too many pitches strike out youth athletes early 2
(Date:8/22/2014)... , Aug. 22, 2014 /CNW/ - On Aug. ... , the Canadian Medical Association (CMA) voted on ... any plant material, including medicinal cannabis. Bedrocan Cannabis Corp., ... supportive of the CMA motion. The CMA ... particular hazards associated with smoking any plant material, including ...
(Date:8/22/2014)... Aug. 22, 2014 Research and Markets ... Research Products: Opportunities, Tools & Technologies" report to ... stem cell research products or you wish to expand ... lucrative this market is. The authors know you want ... effectively to scientists, to generate improved revenues and take ...
(Date:8/22/2014)... Mich. , Aug. 22, 2014  Dr. ... Who with the Diamond Lifetime Achievement Award in the ... as CEO of Cardiovascular Clinical Associates. Dr. ... in managing all major aspects of the business; overseeing ... well as primary coronary intervention. In addition, he is ...
Breaking Medicine Technology:Bedrocan Canada Statement Regarding Canadian Medical Association Motion on Smoking Marijuana 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 2Global Stem Cell Research Products: Opportunities, Tools & Technologies - 2014 Report 3Dr. Mark Rasak, MD is recognized by Continental Who's Who with the Diamond Lifetime Achievement Award 2
... in combination with the most commonly used doses of ... patients with mixed dyslipidemiaORLANDO, Fla., March 29 Data ... TRILIPIX(R) (fenofibric acid) delayed-release capsules in combination with rosuvastatin ... TRILIPIX 135 mg in combination with rosuvastatin calcium 5 ...
... March 29 A new analysis from the,JUPITER ... the risk of venous thromboembolism (VTE) by 43% ... with low to normal cholesterol levels and elevated,high-sensitivity ... the 58th Annual American College of Cardiology Scientific ...
Cached Medicine Technology:New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 2New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 3New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 4New Data for Abbott's TRILIPIX(R) (fenofibric acid) in Combination with Rosuvastatin Calcium Shows Improvement on Key Lipids for Cholesterol Management 5CRESTOR(R) Reduced Risk of Blood Clots in the Veins 2CRESTOR(R) Reduced Risk of Blood Clots in the Veins 3CRESTOR(R) Reduced Risk of Blood Clots in the Veins 4
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
Medicine Products: